inTest Shares: A Silver Lining Amidst a Sharp Decline

Following a disappointing quarterly earnings report, inTest Corporation’s stock experienced a significant sell-off. Although revenues fell short of expectations, prompting a drop of over 13% in the share price, a surprising surge in new orders provided a glimmer of hope for investors.

Despite the negative headlines, a deeper look reveals a powerful counter-narrative. The company’s order intake exploded, soaring 34.2% year-over-year to reach $37.6 million. This marks the highest level seen since the second quarter of 2022. Even more impressive is the backlog, which climbed to a near-record $49.3 million.

Key order metrics include:
* Order Intake: Increased 34.2% compared to the prior year.
* Order Backlog: Reached $49.3 million.
* Read more...